The 2020 Mid-Year Economic Update_long

McKesson to Acquire Vantage Oncology & Biologics

Both companies will become part of McKessons specialty health business.

McKesson Corp. (NYSE: MCK), San Francisco, CA, has agreed to acquire Vantage Oncology LLC, a provider of radiation oncology, medical oncology and integrated cancer care, and Biologics Inc., an oncology pharmacy services company. The combined transactions are valued at $1.2 billion.

Both Vantage and Biologics will become part of McKesson’s specialty health business. Collectively, these acquisitions will increase McKesson’s specialty pharmaceutical distribution scale, oncology-focused pharmacy offerings, solutions for manufacturers and payers, and scope of community-based oncology and practice management services available to providers and patients.

About the Author
Leave a Reply

Leave a Comment

Sign Up for the MDM Update Newsletter

The MDM update newsletter is your best source for news and trends in the wholesale distribution industry.

By subscribing, you are agreeing to MDM’s Privacy Policy.
Social Media Auto Publish Powered By :